Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age

Resumen documental de ASEM

Official National Advisory Committee on Immunization document (2022) on “Archived 35: Summary of NACI statement of March 17, 2022: Recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age”. Summary of NACI recommendations on the use of Moderna Spikevax COVID-19 vaccine in children 6 to 11 years of age: Overview, what you need to know and quotes.

Este resumen facilita la identificación del documento. Para consultar recomendaciones clínicas, consulte siempre la versión oficial vigente y su fecha de actualización.